PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Aurora Cannabis Inc. (ACB)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINCA05156X8843
CUSIP05156X884
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic

Highlights

Market Cap$158.34M
EPS-$58.69
Revenue (TTM)$275.88M
Gross Profit (TTM)$21.23M
EBITDA (TTM)-$33.33M
Year Range$2.84 - $11.50
Target Price$32.04
Short %20.42%
Short Ratio3.66

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ACB

Aurora Cannabis Inc.

Popular comparisons: ACB vs. CURLF, ACB vs. WEED.TO, ACB vs. OGI, ACB vs. CGC, ACB vs. PYPL

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Aurora Cannabis Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%100.00%150.00%OctoberNovemberDecember2024FebruaryMarch
-97.03%
160.07%
ACB (Aurora Cannabis Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Aurora Cannabis Inc. had a return of -33.22% year-to-date (YTD) and -56.44% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-33.22%7.28%
1 month-19.08%2.23%
6 months-67.64%14.98%
1 year-56.44%30.65%
5 years (annualized)-69.54%12.59%
10 years (annualized)N/A10.61%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-20.18%-17.39%
2023-14.66%21.82%-24.56%4.24%3.52%

Risk-Adjusted Performance

Risk-Adjusted Performance Indicators

This table presents risk-adjusted performance metrics for Aurora Cannabis Inc. (ACB) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
ACB
Aurora Cannabis Inc.
-0.56
^GSPC
S&P 500
2.64

Sharpe Ratio

The current Aurora Cannabis Inc. Sharpe ratio is -0.56. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00OctoberNovemberDecember2024FebruaryMarch
-0.56
2.64
ACB (Aurora Cannabis Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Aurora Cannabis Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2024FebruaryMarch
-99.78%
-1.12%
ACB (Aurora Cannabis Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Aurora Cannabis Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Aurora Cannabis Inc. was 99.80%, occurring on Mar 14, 2024. The portfolio has not yet recovered.

The current Aurora Cannabis Inc. drawdown is 99.78%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.8%Jan 24, 20181545Mar 14, 2024
-78.02%Jan 12, 201554Sep 4, 2015232Sep 19, 2016286
-50.55%Jul 14, 20149Aug 1, 20144Sep 8, 201413
-39.39%Apr 11, 201737Jun 6, 201785Oct 5, 2017122
-36.61%Nov 21, 201613Dec 8, 201683Apr 10, 201796

Volatility

Volatility Chart

The current Aurora Cannabis Inc. volatility is 20.35%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%60.00%70.00%OctoberNovemberDecember2024FebruaryMarch
20.35%
3.36%
ACB (Aurora Cannabis Inc.)
Benchmark (^GSPC)

Financials

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM2023202220212020
Revenue

Total Revenue

250.19M233.29M221.34M245.25M278.91M

Cost Of Revenue

166.51M297.65M200.11M266.81M312.45M

Gross Profit

83.67M-64.36M21.23M-21.56M-33.54M
Operating Expenses

Selling, General & Admin Expenses

103.97M183.14M126.97M139.68M265.18M

R&D Expenses

5.40M6.56M10.39M11.45M26.07M

Total Operating Expenses

184.59M189.96M240.60M225.09M450.93M
Income

Income Before Tax

-189.09M-295.42M-1.72B-699.80M-3.38B

Operating Income

-115.59M-254.32M-231.45M-282.82M-490.96M

EBIT

-92.15M-254.32M-236.75M-235.28M-508.12M

Earnings From Continuing Operations

-47.17M-1.75B-1.72B-693.48M-3.30B

Net Income

-174.95M-265.33M-1.72B-693.63M-3.31B

Income Tax Expense

-8.18M-20.32M-2.14M-6.32M-83.40M

Interest Expense

25.43M39.46M71.81M66.44M77.54M

Other Non-Operating Income (Expenses)

-87.95M-41.10M-1.43B-392.46M-2.83B

Extraordinary Items

0.000.000.000.00-9.84M

Discontinued Operations

-12.25M0.000.00-1.61M-9.84M

Effect Of Accounting Charges

0.000.000.000.000.00

Non Recurring

0.000.000.000.000.00

Minority Interest

1.06M2.06M355.00K1.46M-24.36M

Other Items

0.000.000.000.000.00
Values in null except per share items